Literature DB >> 2021534

Distribution of c-yes-1 gene product in various cells and tissues.

K Sugawara1, I Sugawara, J Sukegawa, T Akatsuka, T Yamamoto, M Morita, S Mori, K Toyoshima.   

Abstract

The distribution and degree of expression of c-yes-1 gene product in a variety of cell lines, human foetal tissues, and adult normal and malignant tissues were examined using immunohistochemical techniques. A murine monoclonal antibody 1B7 raised against a fusion protein consisting of 64 amino acid residues from the N-terminus of the c-yes-1 gene product and bacterial phosphate-binding protein (PBP) was used. At the ultrastructural level, the c-yes-1 gene product recognised by 1B7 was localised in the cytoplasm. Moderate to strong expression of the c-yes-1 gene product was observed in HT10-80 (fibrosarcoma). IN-1 (malignant lymphoma), Marcus (glioblastoma), TIG-1-20 (foetal skin fibroblast), proximal tubules of foetal and adult kidney, one of four breast cancers, one of four colorectal cancers, 14 of 33 head and neck cancers, 13 of 24 renal cancers, three of 19 lung cancers and one of seven stomach cancers. These results were further confirmed by Western blotting. Histological types showing moderate to strong expression of the c-yes-1 gene product were renal cell carcinoma (13/24) and squamous cell carcinoma (15/38). The fact that the c-yes-1 gene product is expressed preferentially in renal cell carcinoma and squamous cell carcinoma may indicate that it plays an important role.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021534      PMCID: PMC1972359          DOI: 10.1038/bjc.1991.121

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine.

Authors:  A D Levinson; H Oppermann; H E Varmus; J M Bishop
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

4.  Unifected avian cells contain structurally unrelated progenitors of viral sarcoma genes.

Authors:  M Yoshida; S Kawai; K Toyoshima
Journal:  Nature       Date:  1980-10-16       Impact factor: 49.962

5.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity.

Authors:  S Kawai; M Yoshida; K Segawa; H Sugiyama; R Ishizaki; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus.

Authors:  N Kitamura; A Kitamura; K Toyoshima; Y Hirayama; M Yoshida
Journal:  Nature       Date:  1982-05-20       Impact factor: 49.962

8.  Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine.

Authors:  M S Collett; A F Purchio; R L Erikson
Journal:  Nature       Date:  1980-05-15       Impact factor: 49.962

9.  Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo.

Authors:  M Barbacid; A V Lauver
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

10.  An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.

Authors:  D M Barnes; G A Lammie; R R Millis; W L Gullick; D S Allen; D G Altman
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

View more
  7 in total

1.  Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFR.

Authors:  Kei-Ichiro Arimoto; Stephanie Weng; Dong-Er Zhang
Journal:  Receptors Clin Investig       Date:  2014

2.  Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3.

Authors:  Kazunori Hamamura; Momoko Tsuji; Hiroshi Hotta; Yuki Ohkawa; Masataka Takahashi; Hidenobu Shibuya; Hideyuki Nakashima; Yoshio Yamauchi; Noboru Hashimoto; Hisashi Hattori; Minoru Ueda; Keiko Furukawa; Koichi Furukawa
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

3.  Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers.

Authors:  Erhan Bilal; Gabriela Alexe; Ming Yao; Lei Cong; Atul Kulkarni; Vasudeva Ginjala; Deborah Toppmeyer; Shridar Ganesan; Gyan Bhanot
Journal:  Genes Cancer       Date:  2010-10

4.  Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.

Authors:  Chunmin Yang; Afsar Alam; Fahad A Alhumaydhi; Mohd Shahnawaz Khan; Suliman A Alsagaby; Waleed Al Abdulmonem; Md Imtaiyaz Hassan; Anas Shamsi; Bilqees Bano; Dharmendra Kumar Yadav
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

5.  Gene expression profile of multiple myeloma cell line treated by arsenic trioxide.

Authors:  Mengchang Wang; Shaanxi Liu; Pengbo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

6.  Identification of potent Yes1 kinase inhibitors using a library screening approach.

Authors:  Paresma R Patel; Hongmao Sun; Samuel Q Li; Min Shen; Javed Khan; Craig J Thomas; Mindy I Davis
Journal:  Bioorg Med Chem Lett       Date:  2013-05-29       Impact factor: 2.823

7.  Transforming growth factor-alpha expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate.

Authors:  J Deguchi; T Kawabata; A Kondo; S Okada
Journal:  Jpn J Cancer Res       Date:  1993-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.